{"entity":{"type":"insider","cik":"0001689394","url":"/insider/0001689394","json_url":"/insider/0001689394.json","name":"Catelani Michael","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":6,"first":"2018-09-19","last":"2025-01-15","span_basis":"filed_date"},"name_variants":[{"name":"Catelani Michael","source":"filing","n_filings":6,"first_seen":"2018-09-19","last_seen":"2025-01-15"}],"transactions":[{"id":5048967,"accession":"0001493152-25-002314","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-25-002314","line_url":"/filing/0001493152-25-002314#line-1","is_derivative":false,"issuer_cik":"0000715446","issuer_name":"Anixa Biosciences Inc","issuer_ticker":"ANIX","issuer_name_source":null,"issuer_url":"/issuer/0000715446","owner_cik":"0001689394","owner_name":"Catelani Michael","owner_display_name":"Catelani Michael","owner_url":"/insider/0001689394","role":"Officer (President, COO, & CFO)","role_mark":"O","role_mark_label":"Officer (President, COO, & CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, COO, & CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9289.0,"shares_display":"9,289","price_per_share":2.15,"price_display":"2.15","price_state":"stated","total_value":19971.35,"total_display":"19,971.35","total_whole":"19,971","shares_owned_after":44500.0,"shares_owned_after_display":"44,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-15","filed_date":"2025-01-15","scope":"insider"},{"id":2867314,"accession":"0001493152-24-023037","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-24-023037","line_url":"/filing/0001493152-24-023037#line-1","is_derivative":false,"issuer_cik":"0000715446","issuer_name":"Anixa Biosciences Inc","issuer_ticker":"ANIX","issuer_name_source":null,"issuer_url":"/issuer/0000715446","owner_cik":"0001689394","owner_name":"Catelani Michael","owner_display_name":"Catelani Michael","owner_url":"/insider/0001689394","role":"Officer (President, COO, & CFO)","role_mark":"O","role_mark_label":"Officer (President, COO, & CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, COO, & CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6250.0,"shares_display":"6,250","price_per_share":2.4,"price_display":"2.40","price_state":"stated","total_value":15000.0,"total_display":"15,000.00","total_whole":"15,000","shares_owned_after":35211.0,"shares_owned_after_display":"35,211","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-07","filed_date":"2024-06-07","scope":"insider"},{"id":8632854,"accession":"0001493152-23-025185","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-23-025185","line_url":"/filing/0001493152-23-025185#line-1","is_derivative":false,"issuer_cik":"0000715446","issuer_name":"Anixa Biosciences Inc","issuer_ticker":"ANIX","issuer_name_source":null,"issuer_url":"/issuer/0000715446","owner_cik":"0001689394","owner_name":"Catelani Michael","owner_display_name":"Catelani Michael","owner_url":"/insider/0001689394","role":"Officer (President, COO & CFO)","role_mark":"O","role_mark_label":"Officer (President, COO & CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, COO & CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5500.0,"shares_display":"5,500","price_per_share":3.64,"price_display":"3.64","price_state":"stated","total_value":20020.0,"total_display":"20,020.00","total_whole":"20,020","shares_owned_after":26655.0,"shares_owned_after_display":"26,655","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-20","filed_date":"2023-07-21","scope":"insider"},{"id":6483666,"accession":"0001493152-22-010689","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-22-010689","line_url":"/filing/0001493152-22-010689#line-1","is_derivative":false,"issuer_cik":"0000715446","issuer_name":"Anixa Biosciences Inc","issuer_ticker":"ANIX","issuer_name_source":null,"issuer_url":"/issuer/0000715446","owner_cik":"0001689394","owner_name":"Catelani Michael","owner_display_name":"Catelani Michael","owner_url":"/insider/0001689394","role":"Officer (President)","role_mark":"O","role_mark_label":"Officer (President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5500.0,"shares_display":"5,500","price_per_share":2.66,"price_display":"2.66","price_state":"stated","total_value":14630.0,"total_display":"14,630.00","total_whole":"14,630","shares_owned_after":18135.0,"shares_owned_after_display":"18,135","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-21","filed_date":"2022-04-22","scope":"insider"},{"id":6544361,"accession":"0001493152-22-010594","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-22-010594","line_url":"/filing/0001493152-22-010594#line-1","is_derivative":false,"issuer_cik":"0000715446","issuer_name":"Anixa Biosciences Inc","issuer_ticker":"ANIX","issuer_name_source":null,"issuer_url":"/issuer/0000715446","owner_cik":"0001689394","owner_name":"Catelani Michael","owner_display_name":"Catelani Michael","owner_url":"/insider/0001689394","role":"Officer (President)","role_mark":"O","role_mark_label":"Officer (President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2509.0,"shares_display":"2,509","price_per_share":2.53,"price_display":"2.53","price_state":"stated","total_value":6347.77,"total_display":"6,347.77","total_whole":"6,348","shares_owned_after":12635.0,"shares_owned_after_display":"12,635","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-20","filed_date":"2022-04-21","scope":"insider"},{"id":6580752,"accession":"0001513162-18-000238","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001513162-18-000238","line_url":"/filing/0001513162-18-000238#line-1","is_derivative":false,"issuer_cik":"0000715446","issuer_name":"ITUS Corp","issuer_ticker":"ITUS","issuer_name_source":null,"issuer_url":"/issuer/0000715446","owner_cik":"0001689394","owner_name":"Catelani Michael","owner_display_name":"Catelani Michael","owner_url":"/insider/0001689394","role":"Officer (COO & CFO)","role_mark":"O","role_mark_label":"Officer (COO & CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO & CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2250.0,"shares_display":"2,250","price_per_share":4.45,"price_display":"4.45","price_state":"stated","total_value":10012.5,"total_display":"10,012.50","total_whole":"10,013","shares_owned_after":2250.0,"shares_owned_after_display":"2,250","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-18","filed_date":"2018-09-19","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":6,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":6,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":6},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000715446","name":"Anixa Biosciences Inc","url":"/issuer/0000715446","role":"Officer (President, COO, & CFO)","n_filings":6,"first_seen":"2018-09-19","last_seen":"2025-01-15"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001689394","retrieved_at":"2026-08-23T15:39:25+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}